Mednet Logo
HomeNephrologyQuestion

Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?

2
4 Answers
Mednet Member
Mednet Member
Nephrology · Rush Medical College

If it is for SIADH, I always start with 7.5 mg.

See this, my fellow and I put together years ago.

Dosing in SIADH: A Tale of Two Tolvaptans

If it is for CHF, I would start with 15 mg as those patients are so pre-renal, their distal delivery is so impaired, and tolvaptan is limited by that. I haven't...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · UCLA

Yes, tolvaptan at 7.5 mg per day can be effective in treating SIADH with a decreased rate of overcorrection.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · Ohio State University Medical Center

Yes, I would, depending on their risk factors. Osmotic demyelination is rare when the sodium is above 120 mEq/L, however, in the presence of risk factors (i.e., cirrhosis, malnutrition, hypokalemia), then I would be more cautious. I still do target a change closer to 8-10 mEq/L in 24 hours. If a pat...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · Southern Utah Kidney And Hypertension Center

Yes. It’s safe to use that way at 7.5 mg, and overcorrection is very rare. Dr. @Dr. First Last’s paper is very nice in explaining that.

Register or Sign In to see full answer

Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L? | Mednet